|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00059267 |
|
Date of registration:
|
22/04/2003 |
|
Primary sponsor: |
|
|
Public title:
|
Prevention of Recurrent Hepatitis B After Liver Transplantation
|
|
Scientific title:
|
Prevention of Recurrent Hepatitis B After Liver Transplantation |
|
Date of first enrolment:
|
June 2001 |
|
Target sample size:
|
500 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00059267 |
|
Study type:
|
Observational |
|
Study design:
|
N/A
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Key inclusion & exclusion criteria
|
- Patients awaiting or had received liver or combined liver-kidney transplantation for
hepatitis B including hepatitis B cirrhosis, hepatitis B liver cancer and fulminant
hepatitis B.
Age minimum:
13 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Acute Liver Failure
|
|
Cirrhosis
|
|
Hepatitis B
|
|
Hepatocellular Carcinoma
|
|
Intervention(s)
|
|
Drug: HBIG, Epivir, Hepsera
|
|
Secondary ID(s)
|
|
NIH HBV-OLT (completed)
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|